文献速递复苏、休克与脓毒症消化、代谢与肾脏急症

电子提醒改善急诊疑似严重感染患者第二剂抗生素及时性的实施:一项准随机对照试验

Implementation of an Electronic Alert to Improve Timeliness of Second Dose Antibiotics for Patients With Suspected Serious Infections in the Emergency Department: A Quasi-Randomized Controlled Trial.
PubMed 文献 · Ann Emerg Med · 2023-01-18
一句话结论在9个急诊科,电子提醒使第二剂抗生素延迟中位减少35分钟,并将重大延迟风险绝对降低13%。

该研究在整合医疗系统内9个急诊科纳入接受头孢吡肟或哌拉西林/他唑巴坦的成人患者,分配至电子提醒组(提醒临床医生在适当间隔重新开具抗生素)或常规治疗组。最终分析纳入420例在第二剂到期时仍在急诊接受治疗的患者。电子提醒与抗生素延迟减少相关(中位差35分钟,95%CI 5至65),并与重大延迟概率降低相关(绝对风险降低13%,95%CI 6至20)。ICU转入、住院死亡率和住院时长无差异。

要点

  • 在9个急诊科接受头孢吡肟或哌拉西林/他唑巴坦的成人患者中,电子提醒使第二剂抗生素延迟中位减少35分钟(95%CI 5至65)。
  • 电子提醒使重大延迟(超过第二剂预期间隔的25%)概率绝对降低13%(95%CI 6至20)。
  • 电子提醒与ICU转入、住院死亡率或住院时长无差异。
  • 最终分析仅纳入420例第二剂到期时仍在急诊接受治疗的患者,总入组1113例。

适用人群与场景

  • 在9个急诊科接受头孢吡肟或哌拉西林/他唑巴坦的成人患者。
  • 最终分析纳入420例在第二剂抗生素到期时仍在急诊接受治疗的患者。

处置流程与药物剂量

  • 电子提醒组:临床决策支持工具提醒急诊临床医生在适当间隔重新开具抗生素,与常规治疗比较。

研究设计与关键结果

  • 研究类型:准随机对照试验;9个急诊科;入组1113例接受头孢吡肟或哌拉西林/他唑巴坦的成人急诊患者,最终分析420例第二剂到期时仍在急诊接受治疗的患者。
  • 主要终点:抗生素给药延迟中位差35分钟(95%CI 5至65),电子提醒组延迟减少。
  • 次要终点:ICU转入、住院死亡率、住院时长无差异。
  • 事后次要终点:重大延迟(超过第二剂预期间隔的25%)概率绝对风险降低13%(95%CI 6至20)。

证据类型、等级与局限

  • 证据类型:准随机对照试验。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 电子提醒可减少急诊第二剂抗生素的延迟长度和频率,对ICU转入、住院死亡率或住院时长无影响。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

STUDY OBJECTIVE: Delays in the second dose of antibiotics in the emergency department (ED) are associated with increased morbidity and mortality in patients with serious infections. We analyzed the influence of clinical decision support to prevent delays in second doses of broad-spectrum antibiotics in the ED.

METHODS: We allocated adult patients who received cefepime or piperacillin/tazobactam in 9 EDs within an integrated health care system to an electronic alert that reminded ED clinicians to reorder antibiotics at the appropriate interval vs usual care. The primary outcome was a median delay in antibiotic administration. Secondary outcomes were rates of intensive care unit (ICU) admission, hospital mortality, and hospital length of stay. We included a post hoc secondary outcome of frequency of major delay (>25% of expected interval for second antibiotic dose).

RESULTS: A total of 1,113 ED patients treated with cefepime or piperacillin/tazobactam were enrolled in the study, of whom 420 remained under ED care when their second dose was due and were included in the final analysis. The clinical decision support tool was associated with reduced antibiotic delays (median difference 35 minutes, 95% confidence interval [CI], 5 to 65). There were no differences in ICU transfers, inpatient mortality, or hospital length of stay. The clinical decision support tool was associated with decreased probability of major delay (absolute risk reduction 13%, 95% CI, 6 to 20).

CONCLUSIONS: The implementation of a clinical decision support alert reminding clinicians to reorder second doses of antibiotics was associated with a reduction in the length and frequency of antibiotic delays in the ED. There was no effect on the rates of ICU transfers, inpatient mortality, or hospital length of stay.

来源:Ann Emerg Med,查看原文。版权归原作者所有。

参考来源

  1. Lee AH, McEvoy DS, Stump T, et al. Implementation of an Electronic Alert to Improve Timeliness of Second Dose Antibiotics for Patients With Suspected Serious Infections in the Emergency Department: A Quasi-Randomized Controlled Trial. Ann Emerg Med. 2023. PMID: 36669909. doi:10.1016/j.annemergmed.2022.10.022

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。